|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 211 - 240 of 324 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Misbadi 150 mg kapseli, kova SPC 2022-06-01.docx
|
PL
|
Resepti
|
Misbadi 75 mg kapseli, kova SPC 2023-11-23
|
PL
|
Resepti
|
Mitomycin Accord 20 mg injektio-infuusiokuiva-aine liuosta varten-virtsarakkoon SPC 2022-02-08
|
PL
|
Resepti
|
Mitomycin Medac 40 mg jauhe ja liuotin liuosta varten, virtsarakkoon SPC 2024-01-16
|
PL
|
Resepti
|
Mitomycin medac, 1 mg-ml, injektio-infuusiokuiva-aine, liuosta varten virtsarakkoon SPC 2024-08-07
|
PL
|
Resepti
|
Mitomycin Substipharm 20 mg, injektio-infuusiokuiva-aine, liuosta varten SPC 2023-06-09
|
PL
|
Resepti
|
Mitomycin Substipharm 20 mg, jauhe ja liuotin liuosta varten, virtsarakkoon SPC 2023-06-09
|
PL
|
Resepti
|
Mitoxantron Ebewe 2 mg-ml infuusiokonsentraatti, liuosta varten SPC 2020-11-11
|
PL
|
Resepti
|
Mivacron 2 mg-ml injektioneste, liuos SPC 2022-01-13
|
|
|
European Medicines Agency's website: Mixtard - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Mobic 15 mg tabletti SPC 2023-06-19
|
PL
|
Resepti
|
Mobic 7.5 mg tabletti SPC 2023-06-19
|
PL
|
Itsehoito
|
Mobilat emulsiovoide SPC 2024-01-30
|
PL
|
Itsehoito
|
Mobilat geeli SPC 2024-01-30
|
PL
|
Resepti
|
Modafinil Orion 100 mg, 200 mg tabletti SPC 2022-07-21
|
|
|
European Medicines Agency's website: Modigraf - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Molnex 10 mg-ml, 20 mg-ml injektioneste,liuos SPC 2024-01-12
|
PL
|
Resepti/itsehoito
|
Momesonex 50 mikrog-annos nenäsumute, suspensio SPC 2023-10-05
|
PL
|
Resepti/itsehoito
|
Mometason Orion 50 mikrog-annos nenäsumute, suspensio SPC 2021-05-26
|
PL
|
Resepti/itsehoito
|
Mommox 50 mikrog-annos nenäsumute, suspensio SPC 2021-02-11
|
PL
|
Resepti
|
Monofer 100 mg-ml injektio--infuusioneste, liuos SPC 2022-07-13
|
PL
|
Resepti
|
Monopex 1 mg-ml silmätipat, liuos, kerta-annospakkaus SPC 2021-08-25
|
PL
|
Resepti
|
Monoprost 50 mikrog-ml silmätipat, liuos SPC 2022-05-02
|
PL
|
Resepti
|
Monoprost 50 mikrog-ml silmätipat, liuos, kerta-annospakkaus SPC 2022-03-09
|
PL
|
Resepti
|
Montelukast Accord 10 mg tabletti, kalvopäällysteinen SPC 2023-07-27
|
PL
|
Resepti
|
Montelukast Accord 4 mg purutabletti SPC 2024-10-09
|
PL
|
Resepti
|
Montelukast Accord 5 mg purutabletti SPC 2024-10-09
|
PL
|
Resepti
|
Montelukast Apotex 4 mg, 5 mg purutabletit, 10 mg tabletti, kalvopäällysteinen SPC 2010-09-03
|
PL
|
Resepti
|
Montelukast Helm 5 mg purutabletit SPC 2010-12-10.doc
|
PL
|
Resepti
|
Montelukast Krka 10 mg tabletti, kalvopäällysteinen SPC 2023-12-14
|
|
| |